About
About Avecho
Board & Leadership
TPM
®
Technology
Portfolio
Pipeline
Cannabinoids
Pharmaceutical
Animal Health
Manufacturing
Invest
Investor Centre
Media Centre
Contact
Hit enter to search or ESC to close
Appendix 3X Notices – Three New Directors
April 22, 2015
Click here to read more
Post navigation
Previous Post
Phosphagenics Initiates Oxycodone Patch Dosing in Phase 2 Clinical Trial
Next Post
Notice of 2015 Annual General Meeting
Related Posts
Phosphagenics Placement Secures A$1.37 million
January 18, 2018
Ashland Purchases Manufacturing Rights for VitalET and TPM
June 20, 2019
August 28, 2019
Quarterly Activities Report and 4C
July 27, 2021
July 27, 2021